骨化三醇对老年骨质疏松性脊柱骨折病人PKP术后骨折愈合的影响

doi:10.3969/j.issn.1003-9198.2024.03.007

摘要/Abstract

摘要： 目的研究骨化三醇用于老年骨质疏松性椎体压缩性骨折(OVCF)病人经皮椎体后凸成形术(PKP)后治疗对骨折愈合和血清骨碱性磷酸酶(BALP)、Ⅰ型前胶原N-端前肽(PINP)、胶原羧基端肽β特殊序列(β-CTX)表达水平的影响。方法纳入2019—2020年我院接受PKP手术的106例OVCF病人为研究对象,并采用随机数表法均分为观察组和对照组,每组53例。对照组PKP术后给予钙剂+阿仑膦酸钠片进行治疗,观察组在此基础上加用骨化三醇进行治疗,2组疗程均为6个月,比较2组临床疗效、Cobb角、Oswestry功能障碍指数(ODI)、骨密度和骨代谢指标的差异。结果 2组治疗6个月有效率分别为90.57%和83.02%,差异无统计学意义(P>0.05),优良率分别为73.58%和52.83%,差异有统计学意义(P<0.05)。2组治疗1、3、6个月时Cobb角和ODI均明显低于治疗前(P<0.05),且观察组治疗6个月时ODI低于对照组,差异有统计学意义(P<0.05)。2组治疗3、6个月时骨密度均明显高于治疗前(P<0.05),且观察组治疗6个月时骨密度高于对照组,差异有统计学意义(P<0.05)。与治疗前相比,2组治疗1、3、6个月时BALP和PINP水平明显升高(P<0.05),β-CTX水平均明显降低(P<0.05),且观察组治疗1、3、6个月时BALP和PINP水平均高于对照组,差异有统计学意义(P<0.05)。结论 OVCF病人PKP术后应用骨化三醇进行治疗具有良好效果,有利于改善骨代谢并增加骨密度,对促进骨折愈合、改善脊柱功能和提升日常生活能力具有积极作用。

关键词: 骨质疏松性椎体压缩性骨折, 老年人, 经皮椎体后凸成形术, 骨化三醇, 骨碱性磷酸酶, Ⅰ型前胶原N-端前肽, 胶原羧基端肽β特殊序列

Abstract: Objective To study the effects of calcitriol on fracture healing and the levels of serum bone alkaline phosphatase (BALP), procollagen type Ⅰ N-terminal propeptide (PINP) and β-type Ⅰ collagen carboxyl terminal peptide (β-CTX) in the elderly patients with osteoporotic vertebral compression fractures (OVCF) receiving percutaneous kyphoplasty (PKP). Methods A total of 106 patients with OVCF who received PKP surgery in Hanyang Hospital Affiliated to Wuhan University of Science and Technology from January 2019 to December 2020 were enrolled in this study. And they were divided into control group and observation group according to the random number table method, with 53 cases in each group. The control group was treated with calcium combined with alendronate sodium tablets after PKP surgery, while the observation group was additionally given calcitriol. The course of treatment in both groups was 6 months. The clinical efficacy and the levels of Cobb angle, Oswestry disability index (ODI), bone mineral density and bone metabolism indicators were compared between the two groups. Results The effective rates in the observation group and the control group after 6 months of treatment were 90.57% and 83.02% (P>0.05), and the excellent and good rates were 73.58% and 52.83% (P<0.05). The levels of Cobb angle and ODI in the two groups after 1, 3 and 6 months of treatment were significantly lower than those before treatment (P<0.05), and the level of ODI in the observation group was significantly lower than that in the control group after 6 months of treatment (P<0.05). The bone mineral density after 3 and 6 months of treatment in both groups were significantly higher than those before treatment (P<0.05), and the bone mineral density after 6 months of treatment in the observation group was higher than that in the control group (P<0.05). The levels of BALP and PINP were significantly increased after 1, 3 and 6 months of treatment (P<0.05), while the level of β-CTX was significantly decreased (P<0.05) in the two groups, and the levels of BALP and PINP in the observation group were higher than those in the control group after 1, 3 and 6 months of treatment (P<0.05). Conclusions Calcitriol shows good effects in the treatment of patients with OVCF after PKP surgery through improving the bone metabolism and enhancing the bone mineral density, and it could promote the fracture healing.

Key words: osteoporotic vertebral compression fracture, aged, percutaneous kyphoplasty, calcitriol, bone alkaline phosphatase, procollagen type Ⅰ N-terminal propeptide, β-type Ⅰ collagen carboxyl terminal peptide

中图分类号:

R 683.2

叶恒, 张卫华, 韩俊, 张建业, 李永鸿. 骨化三醇对老年骨质疏松性脊柱骨折病人PKP术后骨折愈合的影响[J]. 实用老年医学, 2024, 38(3): 240-244.

YE Heng, ZHANG Weihua, HAN Jun, ZHANG Jianye, LI Yonghong. Effects of calcitriol on fracture healing in elderly patients with osteoporotic vertebral fractures undergoing PKP surgery[J]. Practical Geriatrics, 2024, 38(3): 240-244.

参考文献

[1] 中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及"健康骨骼"专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.
[2] 赵凯平,袁蕊,马楠,等. 55岁以上原发骨质疏松性骨折患者特征及趋势分析[J].中国骨质疏松杂志,2020,26(6):849-856.
[3] COLLINET A, CHARLES Y P, NTILIKINA Y, et al.Analysis of intervertebral discs adjacent to thoracolumbar A3 fractures treated by percutaneous instrumentation and kyphoplasty[J].Orthop Traumatol Surg Res,2020,106(6):1221-1226.
[4] WANG F, WANG L F, MIAO D C, et al.Which one is more effective for the treatment of very severe osteoporotic vertebral compression fractures: PVP or PKP?[J].J Pain Res,2018,11:2625-2631.
[5] 胡衍,陈晓,苏佳灿.骨质疏松性骨折诊疗误区与"三位一体"骨修复策略[J].中华创伤杂志,2021,37(2):101-106.
[6] LOUGHRAN G,JUNGREIS I,TZANI I,et al.Stop codon readthrough generates a C-terminally extended variant of the human vitamin D receptor with reduced calcitriol response[J]. J Biol Chem,2018,293(12):4434-4444.
[7] 中华医学会骨科学分会青年骨质疏松学组,中国医师协会急救复苏专业委员会创伤骨科与多发伤学组,上海市中西医结合学会骨质疏松专业委员会.中国骨质疏松性骨折围手术期处理专家共识(2018)[J].中国临床医学,2018,25(5):860-866.
[8] LIU X, YUAN S, TIAN Y, et al.Comparison of percutaneous endoscopic transforaminal discectomy, microendoscopic discectomy, and microdiscectomy for symptomatic lumbar disc herniation: minimum 2-year follow-up results[J].J Neurosurg Spine,2018,28(3):317-325.
[9] 程继伟,王振林,刘伟,等. Oswestry功能障碍指数的改良及信度和效度检验[J].中国脊柱脊髓杂志,2017,27(3):235-241.
[10] 郑苗,魏祺,徐又佳.重视骨质疏松性骨折后康复治疗[J].中国骨质疏松杂志,2022,28(4):619-624.
[11] SAITO Y, NAKAMURA S, CHINEN N, et al.Effects of anti-osteoporosis drugs against dexamethasone-induced osteoporosis-like phenotype using a zebrafish scale-regeneration model[J]. J Pharmacol Sci,2020,143(2):117-121.
[12] 陈敏敏,吴筱磬,杜艳萍,等. 骨化三醇对原发性低骨量患者血甲状旁腺素水平骨转换及肌力的作用[J].中华老年医学杂志,2019,38(8):864-868.
[13] LI A,CONG Q,XIA X,et al.Pharmacologic calcitriol inhibits osteoclast lineage commitment via the BMP-Smad1 and IκB-NF-κB pathways[J].J Bone Miner Res,2017,32(7):1406-1420.
[14] 姜天缘,夏超,胡燕,等. 骨化三醇保护间充质干细胞免受H2 O2诱导的氧化应激和成骨损伤[J].医学分子生物学杂志,2019,16(6):494-500.
[15] 陈晓婷,姜天缘,夏超,等. 骨化三醇通过PI3K/AKT促进BMP9诱导的间充质干细胞成骨分化作用[J].医用生物力学,2019,34(2):200-206.
[16] 王皓,凃峰,赵文斌,等. 基于BMP-2/SMAD/Runx2通路探究骨化三醇胶囊对大鼠胫骨骨折愈合的影响[J].中国骨质疏松杂志,2022,28(1):47-51.
[17] LIAO E Y, ZHANG Z L, XIA W B, et al.Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China[J].Medicine: Baltimore, 2018, 97(31):e11694.
[18] NIZET A,CAVALIER E,STENVINKEL P,et al.Bone alkaline phosphatase:an important biomarker in chronic kidney disease - mineral and bone disorder[J].Clin Chim Acta,2020,501:198-206.
[19] FURUGEN M, WATANABE N, NISHINO S, et al.Impact of osteogenic activity on degenerative aortic valve disease in patients with osteoporotic hip fracture[J].J Cardiol,2021,78(5):423-430.
[20] SONG B, LI X, ZHOU Q, et al.Application of bone turnover markers PICP and β-CTx in the diagnosis and treatment of breast cancer with bone metastases[J].Clin Lab,2018,64(1):11-16.